Financials

  • Market Capitalization 126.11 M
  • Employee 118
  • Founded 2010
  • CEO N/A
  • Website www.cibus.com
  • Headquarter Delaware, United States
  • FIGI BBG00H1CJS11
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.94
Relación precio/flujo de caja
18.65

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3833
VTVT
vTv Therapeutics Inc. - Class A Common Stock
32.36 USD-1.34%-3.14%+0.12%+57.85%127.95 M USD
3836
AARD
Aardvark Therapeutics, Inc. - Common Stock
5.79 USD-12.54%-14.22%-12.93%-54.08%126.71 M USD
3842
BMEA
Biomea Fusion, Inc. - Common Stock
1.73 USD+2.98%+15.33%+47.86%-11.73%125.40 M USD
3850
ENGN
enGene Therapeutics Inc. - Common Stock
1.83 USD-4.19%+2.23%+2.23%-78.21%122.59 M USD

Noticias